Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Current Liabilities (2018 - 2025)

AVITA Medical (RCEL) has disclosed Total Current Liabilities for 4 consecutive years, with $62.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 210.93% year-over-year to $62.7 million, compared with a TTM value of $62.7 million through Dec 2025, up 210.93%, and an annual FY2025 reading of $62.7 million, up 210.93% over the prior year.
  • Total Current Liabilities was $62.7 million for Q4 2025 at AVITA Medical, up from $61.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $62.7 million in Q4 2025 and bottomed at $6.5 million in Q1 2022.
  • Average Total Current Liabilities over 4 years is $22.4 million, with a median of $13.5 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities fell 0.17% in 2024, then surged 354.07% in 2025.
  • Year by year, Total Current Liabilities stood at $10.7 million in 2022, then increased by 23.44% to $13.2 million in 2023, then skyrocketed by 52.72% to $20.2 million in 2024, then surged by 210.93% to $62.7 million in 2025.
  • Business Quant data shows Total Current Liabilities for RCEL at $62.7 million in Q4 2025, $61.8 million in Q3 2025, and $62.6 million in Q2 2025.